SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-009862
Filing Date
2023-09-06
Accepted
2023-09-06 17:30:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27657
2 filename2.txt TEXT-EXTRACT 1497
  Complete submission text file 0000000000-23-009862.txt   40287
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filed for) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)